These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 16145866

  • 1. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
    Jakić-Razumović J, Corić M, Vrbanec D, Babić D, Hlupić L, Belev B.
    Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
    [Abstract] [Full Text] [Related]

  • 2. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
    Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.
    Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.
    Anticancer Res; 2002 Aug; 22(4):2493-9. PubMed ID: 12174951
    [Abstract] [Full Text] [Related]

  • 5. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M.
    Ann Acad Med Stetin; 2009 Aug; 55(1):22-30. PubMed ID: 20349588
    [Abstract] [Full Text] [Related]

  • 6. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z, Khurshid A, Qureshi A, Idress R, Asghar N, Kayani N.
    Indian J Pathol Microbiol; 2009 Aug; 52(4):477-81. PubMed ID: 19805950
    [Abstract] [Full Text] [Related]

  • 7. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.
    Pirinen R, Lipponen P, Syrjänen K.
    Anticancer Res; 1995 Feb; 15(6B):2835-40. PubMed ID: 8669874
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A.
    Cancer; 2003 Sep 01; 98(5):1055-60. PubMed ID: 12942575
    [Abstract] [Full Text] [Related]

  • 13. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
    Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjänen K.
    Anticancer Res; 1991 Sep 01; 11(5):1701-6. PubMed ID: 1768039
    [Abstract] [Full Text] [Related]

  • 14. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
    Ko SS, Na YS, Yoon CS, Park JY, Kim HS, Hur MH, Lee HK, Chun YK, Kang SS, Park BW, Lee JH.
    Int J Surg Pathol; 2007 Apr 01; 15(2):98-109. PubMed ID: 17478762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Cathepsin D in primary breast cancer in correlation with various prognostic factors].
    Rempen A, Caffier H.
    Geburtshilfe Frauenheilkd; 1991 Apr 01; 51(4):272-5. PubMed ID: 1650323
    [Abstract] [Full Text] [Related]

  • 17. Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis.
    Van Belle V, Van Calster B, Brouckaert O, Vanden Bempt I, Pintens S, Harvey V, Murray P, Naume B, Wiedswang G, Paridaens R, Moerman P, Amant F, Leunen K, Smeets A, Drijkoningen M, Wildiers H, Christiaens MR, Vergote I, Van Huffel S, Neven P.
    J Clin Oncol; 2010 Sep 20; 28(27):4129-34. PubMed ID: 20713855
    [Abstract] [Full Text] [Related]

  • 18. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 19. The importance of prognostic factors in premenopausal women with breast cancer.
    Finek J, Holubec L, Topolcan O, Elgrova L, Skalova A, Pecen L.
    Anticancer Res; 2007 Aug 01; 27(4A):1893-6. PubMed ID: 17649790
    [Abstract] [Full Text] [Related]

  • 20. [Prognostic significance of newly formed blood vessels in the tumors of patients with breast cancer].
    Jakić-Razumović J, Blazicević V, Uzarević B, Petrovecki M.
    Lijec Vjesn; 2002 May 01; 124(5):123-8. PubMed ID: 12152410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.